Cardiovascular Diabetology,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: Sept. 25, 2023
Abstract
Artificial
intelligence
and
machine
learning
are
driving
a
paradigm
shift
in
medicine,
promising
data-driven,
personalized
solutions
for
managing
diabetes
the
excess
cardiovascular
risk
it
poses.
In
this
comprehensive
review
of
applications
care
patients
with
at
increased
risk,
we
offer
broad
overview
various
data-driven
methods
how
they
may
be
leveraged
developing
predictive
models
care.
We
existing
as
well
expected
artificial
context
diagnosis,
prognostication,
phenotyping,
treatment
its
complications.
addition
to
discussing
key
properties
such
that
enable
their
successful
application
complex
prediction,
define
challenges
arise
from
misuse
role
methodological
standards
overcoming
these
limitations.
also
identify
issues
equity
bias
mitigation
healthcare
discuss
current
regulatory
framework
should
ensure
efficacy
safety
medical
products
transforming
outcomes
diabetes.
BMC Medical Education,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Sept. 22, 2023
Abstract
Introduction
Healthcare
systems
are
complex
and
challenging
for
all
stakeholders,
but
artificial
intelligence
(AI)
has
transformed
various
fields,
including
healthcare,
with
the
potential
to
improve
patient
care
quality
of
life.
Rapid
AI
advancements
can
revolutionize
healthcare
by
integrating
it
into
clinical
practice.
Reporting
AI’s
role
in
practice
is
crucial
successful
implementation
equipping
providers
essential
knowledge
tools.
Research
Significance
This
review
article
provides
a
comprehensive
up-to-date
overview
current
state
practice,
its
applications
disease
diagnosis,
treatment
recommendations,
engagement.
It
also
discusses
associated
challenges,
covering
ethical
legal
considerations
need
human
expertise.
By
doing
so,
enhances
understanding
significance
supports
organizations
effectively
adopting
technologies.
Materials
Methods
The
investigation
analyzed
use
system
relevant
indexed
literature,
such
as
PubMed/Medline,
Scopus,
EMBASE,
no
time
constraints
limited
articles
published
English.
focused
question
explores
impact
applying
settings
outcomes
this
application.
Results
Integrating
holds
excellent
improving
selection,
laboratory
testing.
tools
leverage
large
datasets
identify
patterns
surpass
performance
several
aspects.
offers
increased
accuracy,
reduced
costs,
savings
while
minimizing
errors.
personalized
medicine,
optimize
medication
dosages,
enhance
population
health
management,
establish
guidelines,
provide
virtual
assistants,
support
mental
care,
education,
influence
patient-physician
trust.
Conclusion
be
used
diagnose
diseases,
develop
plans,
assist
clinicians
decision-making.
Rather
than
simply
automating
tasks,
about
developing
technologies
that
across
settings.
However,
challenges
related
data
privacy,
bias,
expertise
must
addressed
responsible
effective
healthcare.
BMJ,
Journal Year:
2020,
Volume and Issue:
unknown, P. m689 - m689
Published: March 25, 2020
Abstract
Objective
To
systematically
examine
the
design,
reporting
standards,
risk
of
bias,
and
claims
studies
comparing
performance
diagnostic
deep
learning
algorithms
for
medical
imaging
with
that
expert
clinicians.
Design
Systematic
review.
Data
sources
Medline,
Embase,
Cochrane
Central
Register
Controlled
Trials,
World
Health
Organization
trial
registry
from
2010
to
June
2019.
Eligibility
criteria
selecting
Randomised
registrations
non-randomised
a
algorithm
in
contemporary
group
one
or
more
Medical
has
seen
growing
interest
research.
The
main
distinguishing
feature
convolutional
neural
networks
(CNNs)
is
when
CNNs
are
fed
raw
data,
they
develop
their
own
representations
needed
pattern
recognition.
learns
itself
features
an
image
important
classification
rather
than
being
told
by
humans
which
use.
selected
aimed
use
predicting
absolute
existing
disease
into
groups
(eg,
non-disease).
For
example,
chest
radiographs
tagged
label
such
as
pneumothorax
no
CNN
pixel
patterns
suggest
pneumothorax.
Review
methods
Adherence
standards
was
assessed
using
CONSORT
(consolidated
trials)
randomised
TRIPOD
(transparent
multivariable
prediction
model
individual
prognosis
diagnosis)
studies.
Risk
bias
tool
PROBAST
(prediction
assessment
tool)
Results
Only
10
records
were
found
clinical
trials,
two
have
been
published
(with
low
except
lack
blinding,
high
adherence
standards)
eight
ongoing.
Of
81
trials
identified,
only
nine
prospective
just
six
tested
real
world
setting.
median
number
experts
comparator
four
(interquartile
range
2-9).
Full
access
all
datasets
code
severely
limited
(unavailable
95%
93%
studies,
respectively).
overall
58
suboptimal
(<50%
12
29
items).
61
stated
abstract
artificial
intelligence
at
least
comparable
(or
better
than)
31
(38%)
further
required.
Conclusions
Few
exist
imaging.
Most
not
prospective,
deviate
standards.
availability
lacking
most
human
often
small.
Future
should
diminish
enhance
relevance,
improve
transparency,
appropriately
temper
conclusions.
Study
registration
PROSPERO
CRD42019123605.
npj Digital Medicine,
Journal Year:
2021,
Volume and Issue:
4(1)
Published: April 7, 2021
Deep
learning
(DL)
has
the
potential
to
transform
medical
diagnostics.
However,
diagnostic
accuracy
of
DL
is
uncertain.
Our
aim
was
evaluate
algorithms
identify
pathology
in
imaging.
Searches
were
conducted
Medline
and
EMBASE
up
January
2020.
We
identified
11,921
studies,
which
503
included
systematic
review.
Eighty-two
studies
ophthalmology,
82
breast
disease
115
respiratory
for
meta-analysis.
Two
hundred
twenty-four
other
specialities
qualitative
Peer-reviewed
that
reported
on
using
imaging
included.
Primary
outcomes
measures
accuracy,
study
design
reporting
standards
literature.
Estimates
pooled
random-effects
In
AUC's
ranged
between
0.933
1
diagnosing
diabetic
retinopathy,
age-related
macular
degeneration
glaucoma
retinal
fundus
photographs
optical
coherence
tomography.
imaging,
0.864
0.937
lung
nodules
or
cancer
chest
X-ray
CT
scan.
For
0.868
0.909
mammogram,
ultrasound,
MRI
digital
tomosynthesis.
Heterogeneity
high
extensive
variation
methodology,
terminology
outcome
noted.
This
can
lead
an
overestimation
There
immediate
need
development
artificial
intelligence-specific
EQUATOR
guidelines,
particularly
STARD,
order
provide
guidance
around
key
issues
this
field.
npj Digital Medicine,
Journal Year:
2022,
Volume and Issue:
5(1)
Published: Jan. 10, 2022
While
the
opportunities
of
ML
and
AI
in
healthcare
are
promising,
growth
complex
data-driven
prediction
models
requires
careful
quality
applicability
assessment
before
they
applied
disseminated
daily
practice.
This
scoping
review
aimed
to
identify
actionable
guidance
for
those
closely
involved
AI-based
model
(AIPM)
development,
evaluation
implementation
including
software
engineers,
data
scientists,
professionals
potential
gaps
this
guidance.
We
performed
a
relevant
literature
providing
or
criteria
regarding
evaluation,
AIPMs
using
comprehensive
multi-stage
screening
strategy.
PubMed,
Web
Science,
ACM
Digital
Library
were
searched,
experts
consulted.
Topics
extracted
from
identified
summarized
across
six
phases
at
core
review:
(1)
preparation,
(2)
AIPM
(3)
validation,
(4)
(5)
impact
assessment,
(6)
into
From
2683
unique
hits,
72
documents
identified.
Substantial
was
found
development
validation
(phases
1-3),
while
later
clearly
have
received
less
attention
(software
implementation)
scientific
literature.
The
cycle
provide
framework
responsible
introduction
healthcare.
Additional
domain
technology
specific
research
may
be
necessary
more
practical
experience
with
implementing
is
needed
support
further
Nature Communications,
Journal Year:
2020,
Volume and Issue:
11(1)
Published: Oct. 6, 2020
Abstract
Soaring
cases
of
coronavirus
disease
(COVID-19)
are
pummeling
the
global
health
system.
Overwhelmed
facilities
have
endeavored
to
mitigate
pandemic,
but
mortality
COVID-19
continues
increase.
Here,
we
present
a
risk
prediction
model
for
(MRPMC)
that
uses
patients’
clinical
data
on
admission
stratify
patients
by
risk,
which
enables
physiological
deterioration
and
death
up
20
days
in
advance.
This
ensemble
is
built
using
four
machine
learning
methods
including
Logistic
Regression,
Support
Vector
Machine,
Gradient
Boosted
Decision
Tree,
Neural
Network.
We
validate
MRPMC
an
internal
validation
cohort
two
external
cohorts,
where
it
achieves
AUC
0.9621
(95%
CI:
0.9464–0.9778),
0.9760
(0.9613–0.9906),
0.9246
(0.8763–0.9729),
respectively.
expeditious
accurate
stratification
with
COVID-19,
potentially
facilitates
more
responsive
systems
conducive
high
patients.